Early Spatio-Temporal and Cognitive Deficits in Alzheimer's Disease
View abstract on PubMed
Summary
This summary is machine-generated.Temporal order significantly impacts spatial memory in early Alzheimer's disease (eAD) patients, unlike healthy controls. eAD patients anchor to the first presented item, affecting spatial judgments.
Area Of Science
- Cognitive Neuroscience
- Neuropsychology
- Human Spatial Cognition
Background
- Spatial memory relies on egocentric and allocentric frames of reference.
- Alzheimer's disease (AD) impairs spatial memory, particularly allocentric recall.
- Real-world spatial processing is dynamic, yet research often uses static tasks.
Purpose Of The Study
- Investigate the influence of temporal order on spatial memory in early Alzheimer's disease (eAD).
- Compare egocentric and allocentric spatial judgments in eAD patients versus normal controls (NC) under dynamic conditions.
Main Methods
- Utilized a dynamic spatial memory task with 3D objects and a reference bar.
- Participants judged object proximity based on egocentric (self-centered) and allocentric (environment-centered) frames.
- Assessed performance in eAD patients and NC individuals.
Main Results
- Temporal order significantly affected spatial judgments in eAD patients, but not NC.
- eAD patients showed a bias towards the initially presented object.
- NC participants exhibited equal accuracy for first and second presented items.
Conclusions
- eAD patients' difficulty in updating spatial representations in dynamic settings leads to reliance on initial information.
- Findings underscore the importance of understanding cognitive strategies in AD patients.
- Dynamic tasks reveal distinct spatial memory deficits in early Alzheimer's disease.
Related Concept Videos
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...

